Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease.

Abstract:

:Seven males with atherosclerotic disease received daily 1.6 g of the thromboxane antagonist BM 13.177 in two separate oral dosages over a period of four days. The drug significantly reduced elevated plasma levels of thromboxane B2, beta-thromboglobulin and platelet factor 4, whereas thromboxane B2 generation was only slightly depressed. BM 13.177 inhibited platelet aggregation by collagen, and to a minor degree the second wave of ADP induced aggregation. Platelet sensitivity to prostacyclin and aggregation by ristocetin were not altered. Bleeding time was prolonged. All effects disappeared within 24 hours after the last application of the drug. No side effects were noted. Thus BM 13.177 appears to be a safe and effective new antiplatelet drug.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Riess H,Hiller E,Reinhardt B,Bräuning C

doi

10.1016/0049-3848(84)90229-9

subject

Has Abstract

pub_date

1984-08-15 00:00:00

pages

371-8

issue

4

eissn

0049-3848

issn

1879-2472

journal_volume

35

pub_type

杂志文章
  • Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status.

    abstract:INTRODUCTION:Antithrombin (AT), protein C (PC) and protein S (PS) deficiencies are risk factors for venous thromboembolism. Overlapping values between heterozygous carriers and normal individuals often make a correct classification of a deficiency difficult. The aim of this study was to investigate the effect of sex, a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.07.003

    authors: Franchi F,Biguzzi E,Martinelli I,Bucciarelli P,Palmucci C,D'Agostino S,Peyvandi F

    更新日期:2013-08-01 00:00:00

  • Expression and characterization of recombinant protein S with the Ser 460 Pro mutation.

    abstract::To characterize the putative biochemical modifications induced by the Ser 460 to Pro (Heerlen) mutation in protein S (PS), we expressed both wild-type (wt) and mutated recombinant PS in HEK cells. In SDS-polyacrylamide gels, r-PS Heerlen migrated at 71 kDa whereas r-wt PS migrated at 73 kDa, a difference abolished aft...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00296-6

    authors: Morboeuf O,Borgel D,Aiach M,Kaabache T,Gandrille S,Gaussem P

    更新日期:2000-10-01 00:00:00

  • Resistance to activated protein C: evaluation of three functional assays.

    abstract::Resistance to Activated Protein C (APC) was evaluated using 3 different methods: two of them were based on the prolongation of the Activated Partial Thromboplastin Time (APTT) using 2 different APTT reagents in the presence of APC, whereas the third method was based on the prolongation of prothrombin time when APC is ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90206-2

    authors: Vasse M,Leduc O,Borg JY,Chrétien MH,Monconduit M

    更新日期:1994-10-01 00:00:00

  • Heparanase procoagulant effects and inhibition by heparins.

    abstract::Heparanase is an endo-beta-D-glucuronidase capable of cleaving heparan sulfate (HS) side chains of heparan sulfate proteoglycans (HSPG) on cell surfaces and the extracellular matrix, activity that is strongly implicated in tumor metastasis and angiogenesis. Evidence was provided that heparanase over-expression in canc...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/S0049-3848(10)70018-9

    authors: Nadir Y,Brenner B

    更新日期:2010-04-01 00:00:00

  • Should we abandon the APTT for monitoring unfractionated heparin?

    abstract:INTRODUCTION:The activated partial thromboplastin time (APTT) is commonly used to monitor unfractionated heparin (UFH) but may not accurately measure the amount of heparin present. The anti-Xa assay is less susceptible to confounding factors and may be a better assay for this purpose. MATERIALS AND METHODS:The validit...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2017.07.006

    authors: Arachchillage DRJ,Kamani F,Deplano S,Banya W,Laffan M

    更新日期:2017-09-01 00:00:00

  • A multicolor flow cytometric assay for measurement of platelet-derived microparticles.

    abstract:INTRODUCTION:Flow cytometry (FCM) is the most commonly used method for detection of platelet-derived microparticles (PDMPs), but it is poorly standardized and mainly used for "bedside" analyses in fresh samples. If PDMPs could be analyzed in previously frozen samples it would increase the usefulness of the method. Howe...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.10.006

    authors: Mobarrez F,Antovic J,Egberg N,Hansson M,Jörneskog G,Hultenby K,Wallén H

    更新日期:2010-03-01 00:00:00

  • Evaluation of the soluble fibrin monomer complexes and other coagulation parameters in obstetric patients.

    abstract::The soluble fibrin monomer complexes (SFMC) in 154 obstetric patients with possible disseminated intravascular coagulation (DIC) were evaluated in SDS polyacrylamide gel electrophoresis (PAGE) after precipitation with B-alanine. Other coagulation tests were performed on these patients. The patients were classified int...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90007-x

    authors: Aznar J,Gilabert J,Estelles A,Fernandez MA,Villa P,Aznar JA

    更新日期:1982-09-15 00:00:00

  • Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.

    abstract:INTRODUCTION:Unfractionated heparin (UFH) does not cross the placenta and has demonstrated utility in the prevention and treatment of thrombosis during pregnancy. Limited information is available to guide initiation and monitoring of therapeutic UFH targeting an anti-Xa concentration of 0.3-0.7 u/ml during pregnancy. T...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.07.014

    authors: Clark NP,Delate T,Cleary SJ,Witt DM

    更新日期:2010-05-01 00:00:00

  • Placental transfer of Org 10172, a low-molecular weight heparinoid, in the awake late-pregnant guinea pig.

    abstract::The placental transfer of Org 10172, a low-molecular weight heparinoid, was determined in 12 awake late-pregnant guinea pigs. Nine animals receiving placebo served as controls. After 5 days i.v. treatment with Org 10172 (2 x 300 anti-Xa U/kg/day), anti-Xa activity in fetal plasma amounted to 2.4% of the maternal conce...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90002-2

    authors: Peeters LL,Hobbelen PM,Verkeste CM,Vogel GM,Hasenack HG,Meuleman DG,Wallenburg HC

    更新日期:1986-11-01 00:00:00

  • Prevention of VTE in women with cancer.

    abstract::The prevention of venous thromboembolism (VTE) in women with cancer requires special consideration. The presence of cancer results in both non-surgical and surgical patients having increased risk of VTE. This usually leads to a modification of the recommended preventive therapy, affecting the type, dose and length of ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/S0049-3848(11)70003-2

    authors: Cohen AT,Wills JO,Bharathi N,Solis JV

    更新日期:2011-02-01 00:00:00

  • Role of red cells in preventing the growth of platelet aggregation.

    abstract::Using high-resolution real-time two-dimensional ultrasound, we have investigated the role of red cells in the growth of already established platelet aggregates under controlled flow conditions. Platelet rich plasma (PRP) was circulated in vitro in horizontally and vertically arranged tubing at mean shear rate ranging ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90376-1

    authors: Machi J,Sigel B,Ramos JR,Justin JR,Feinberg H,LeBreton GC,Robertson AL Jr

    更新日期:1984-10-01 00:00:00

  • Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders.

    abstract:BACKGROUND:Clauss fibrinogen assay (CFA) is widely used as a screening test to detect fibrinogen disorders. However, CFA alone cannot distinguish quantitative and qualitative defects because it depends on functional fibrinogen activity (Ac), and fibrinogen antigen (Ag) determination is required to classify fibrinogen d...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.12.018

    authors: Suzuki A,Suzuki N,Kanematsu T,Shinohara S,Arai N,Kikuchi R,Matsushita T

    更新日期:2019-02-01 00:00:00

  • The effect of parnaparin sodium on in vitro fertilization outcome: A prospective randomized controlled trial.

    abstract:INTRODUCTION:In-vitro and in-vivo models suggest the influence of low-molecular weight heparin on conception in infertile women undergoing in vitro fertilization procedures (IVF). In this randomized controlled trial we assessed whether a low-molecular weight heparin (parnaparin) could affect IVF outcomes. MATERIALS AN...

    journal_title:Thrombosis research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.thromres.2017.08.006

    authors: Lodigiani C,Dentali F,Banfi E,Ferrazzi P,Librè L,Quaglia I,Cafaro L,Morenghi E,Pacetti V,Zannoni E,Baggiani AM,Levi-Setti PE

    更新日期:2017-11-01 00:00:00

  • Fibrin gel structure and clotting time.

    abstract::Liquid permeation studies of fibrin gels, which were formed in the presence of thrombin (Fibrin II) and in the presence of Batroxobin (Fibrin I), showed that those gels have distinctly different flow properties. For both gels the permeability coefficient (Ks) and average pore size varied depending on the conditions fo...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90214-6

    authors: Blombäck B,Okada M

    更新日期:1982-01-01 00:00:00

  • The use of eConsults to improve access to specialty care in thrombosis medicine.

    abstract:INTRODUCTION:Electronic consultations (eConsults) are asynchronous, consultative electronic-based communications that are aimed to improve efficient and timely access to specialist advice. Our study aim was to evaluate the use and impact of the Canadian Champlain BASE™ (Building Access to Specialists through eConsultat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2017.11.002

    authors: Skeith L,Mohamed M,Karovitch A,Liddy C,Afkham A,Archibald D,Keely E

    更新日期:2017-12-01 00:00:00

  • Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.

    abstract:INTRODUCTION:Medically ill, hospitalized patients are at increased risk for venous thromboembolism (VTE) after discharge. This study aimed to examine thromboprophylaxis patterns, risk factors, and post-discharge outcomes. METHODS:This was a retrospective claims analysis involving administrative claims data and in-pati...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.08.013

    authors: Mahan CE,Fisher MD,Mills RM,Fields LE,Stephenson JJ,Fu AC,Spyropoulos AC

    更新日期:2013-11-01 00:00:00

  • History of rFVIIa therapy.

    abstract::Hemophilia patients with inhibitors against FVIII/FIX present with a major challenge in the clinical practice. In the 1970s such patients were treated in association with emergency situations and essential surgery using huge amounts of FVIII/FIX concentrates often preceded by extracorporal adsorption of antibodies aga...

    journal_title:Thrombosis research

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.thromres.2010.01.021

    authors: Hedner U

    更新日期:2010-04-01 00:00:00

  • The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study.

    abstract::Data on the effect of hormone replacement therapy on hemostasis are inconsistent, and there are few data in women with coronary artery disease. In a single-center, open, randomized study, 118 postmenopausal women with angiographically verified coronary artery disease were randomized to hormone replacement therapy, giv...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(99)00233-9

    authors: Hoibraaten E,Os I,Seljeflot I,Andersen TO,Hofstad A,Sandset PM

    更新日期:2000-04-01 00:00:00

  • Platelet adhesion at low shear rate: study of a normal population.

    abstract::The use of oral contraceptives (OCs) has been associated with vascular complications. The mechanism(s) by which OCs predispose to thrombotic events remains unclear. Recent studies have demonstrated that postmenopausal (PM) women who take estrogen replacement therapy (ERT) have a decreased incidence of myocardial infar...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(93)90043-n

    authors: Dores GM,Miller ME,Thorpe SL

    更新日期:1993-01-15 00:00:00

  • Inhibition of platelet aggregation and endogenous lectin activity by oligoamines.

    abstract::Amino sugars and basic amino acids inhibit platelet aggregation and the activity of the endogenous platelet lectin, yet, relatively high concentrations (approximately 30 mM) are required for the inhibition. If cooperative interactions are involved in these platelet surface activities, oligomers of primary amines shoul...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90160-9

    authors: Agam G,Gartner TK,Livne A

    更新日期:1984-02-01 00:00:00

  • The loss of sialic acid and its prevention in stored human platelets.

    abstract::The loss of sialic acid was determined in human platelets stored during a seven day period in their homologous plasma. Approximately 30% of the sialic acid was lost during the first three days of incubation at room temperature and a total of 73% was lost after seven days. The rapid in vitro loss of sialic acid may mim...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(82)90316-4

    authors: Soslau G,Giles J

    更新日期:1982-06-15 00:00:00

  • Thromboembolic complications several days after a single-dose administration of aspirin.

    abstract::The antithrombotic properties of acetyl salicylic acid (ASA) used at current doses are largely demonstrated. However, our previous study showed unexpected thrombotic potencies associated with the use of this drug. In this study we investigate the effect of aspirin on an experimental thrombosis induced by laser beams, ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(97)00302-2

    authors: Aguejouf O,Belougne-Malfatti E,Doutremepuich F,Belon P,Doutremepuich C

    更新日期:1998-02-01 00:00:00

  • Outer membrane vesicles from Neisseria meningitidis: effects on tissue factor and plasminogen activator inhibitor-2 production in human monocytes.

    abstract::Lipopolysaccharide-containing outer membrane vesicles (OMV-LPS) which are spontaneously released from Neisseria meningitidis during logarithmic growth were studied for their ability to induce procoagulant (tissue factor), profibrinolytic (urokinase-type plasminogen activator) and antifibrinolytic (plasminogen activato...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00256-0

    authors: Mirlashari MR,Høiby EA,Holst J,Lyberg T

    更新日期:2001-05-15 00:00:00

  • Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy.

    abstract::Venous thromboembolism remains an important cause of maternal mortality. For women at risk during pregnancy, the recommended venous thromboembolismprophylaxis is unfractionated heparin. Low molecular weight heparins, such as dalteparin, also may be suitable, but randomised trials have not been performed. Pregnant wome...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0049-3848(99)00110-3

    authors: Pettilä V,Kaaja R,Leinonen P,Ekblad U,Kataja M,Ikkala E

    更新日期:1999-11-15 00:00:00

  • Thermally induced conformational changes in fibrin film.

    abstract::Fibrin film is prepared by compaction in one dimension of a fibrin clot (pH 6.3, ionic strength 0.15, fibrin concentration about 0.5%) by expulsion of fluid to reach a fibrin concentration of about 15%. Strips of film, equilibrated in the same buffer with very slowly increasing temperature, shrink in length in a narro...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90020-5

    authors: Nakatani AI,Ferry JD

    更新日期:1988-12-01 00:00:00

  • Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.

    abstract:OBJECTIVE:The diallelic glycoprotein IIIa polymorphism P1A1/A2 was attributed to be an inherited risk factor for coronary events. Whether this polymorphism affects response to aspirin in patients with coronary artery disease is not known. METHODS:We assessed thrombin generation (prothrombin fragment F1+2) in consecuti...

    journal_title:Thrombosis research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.thromres.2006.03.005

    authors: Dropinski J,Musial J,Sanak M,Wegrzyn W,Nizankowski R,Szczeklik A

    更新日期:2007-01-01 00:00:00

  • Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP.

    abstract::We previously reported that the expression of thrombomodulin on the MEG-01, a cell line from human megakaryoblastic leukemia, was increased by agents that increase intracellular cAMP. In this paper we examine the effect of these agents on cultured human umbilical vein endothelial cells (HUVEC) and mouse hemangioma cel...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(91)90107-8

    authors: Maruyama I,Soejima Y,Osame M,Ito T,Ogawa K,Yamamoto S,Dittman WA,Saito H

    更新日期:1991-02-01 00:00:00

  • Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal.

    abstract:INTRODUCTION:Patients with nonvalvular atrial fibrillation are at increased risk for systemic embolism, predominantly disabling stroke. To study how stroke and mortality rates vary with different degrees of anticoagulation reflected by the international normalised ratio (INR) we critically assess information from diffe...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2004.11.025

    authors: Odén A,Fahlén M,Hart RG

    更新日期:2006-01-01 00:00:00

  • Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.

    abstract::A synthetic pentasaccharide, representing the critical sequence required in heparin for binding to antithrombin III (AT III), produces strong anti-factor Xa activity in vitro in the presence of AT III and is devoid of any activity directed towards thrombin. This pentasaccharide provides a unique tool to study the ques...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90280-5

    authors: Walenga JM,Petitou M,Lormeau JC,Samama M,Fareed J,Choay J

    更新日期:1987-04-15 00:00:00

  • The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.

    abstract:BACKGROUND:It is well demonstrated that obesity is an independent risk factor for cardiovascular diseases. Recent studies have shown that obesity, insulin resistance and atherosclerosis are closely related phenomena in which low-grade inflammatory state and prothrombotic condition has pivotal roles. It has been shown t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.12.019

    authors: Guldiken S,Demir M,Arikan E,Turgut B,Azcan S,Gerenli M,Tugrul A

    更新日期:2007-01-01 00:00:00